ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Clin Pharmacol Biopharm 2020, Vol 9(4): 202
  • DOI: 10.4172/2167-065X.1000202

Galactomannan Fiber and Alkaloids for Hyperlipidemia

M Ismail Khoso1, Saleemullah Abro2, Shah Murad3*, Tarique Ahmed Maka4, Wajid Abro5, Nusratullah Khan6 and Seema Shah Murad7
1Consultant Physician, CMH Mangla, Pakistan
2Department of Physiology, Baqai Medical University, Karachi, Pakistan
3Akbar Niazi Teaching Hospital- IMDC, Islamabad, Pakistan
4ENT Specialist, CMH Mangla, Pakistan
5Department of Biochemistry, Bolan University of Medical and Health Sciences, Quetta, Pakistan
6Department of Microbiology at BMSI, JPMC Karachi, Pakistan
7Consultanat Gynecologist, NMC Karachi, Pakistan
*Corresponding Author : Shah Murad, Akbar Niazi Teaching Hospital and IM&DC, Islamabad, Pakistan, Email: shahhmurad65@gmail.com

Received Date: May 13, 2019 / Accepted Date: Aug 20, 2020 / Published Date: Aug 27, 2020

Abstract

Treatment and control of elevated LDL-C are as primary goals of CVD prevention in guidelines. Both epidemiological and experimental studies confirm the protective effect of high-density lipoprotein cholesterol (HDL-C) on the onset of CAD despite LDL-C level, owing to the reverse cholesterol transport process of HDL-C. However, in recent decades, some researchers assert that other newer lipid measurements, including non-HDL-C, apolipoprotein (apo)A-I, apoB, and lipid ratios, are superior to traditional LDL-C in predicting adverse outcomes in general population. Some researchers even suggest that apoB can replace the standard “lipid profile” as a target for motoring and therapy in at-risk patients. High plasma lipids interact with free radicals in human body leading to develop coronary artery disease. We in this study have compared hypolipidemic effects of Fenugreek, Curcuma longa, and Lemon. Study was conducted at Jinnah Hospital Lahore-Pakistan from January 2018 to May 2018. Ninety hyperlipidemic patients of age group 19 to 70 were included in the study. Exclusion criteria were diabetic, alcoholic additives, hypertensive patients and those whose kidney or liver functions were impaired. Consent was taken from all participants. Their base line lipid profile was taken in biochemistry laboratory of the hospital. They were divided in three groups i.e. 30 patients in each group. Group-I was advised to take 500 mg of Curcuma longa (haldi) mixed in fresh milk without cream, thrice daily for two months. Group-II patients were advised to take 100 grams of Fenugreek leaves mixed with salad in each meal (thrice daily) for the period of two months. Group-III patients were advised to take 40 ml of fresh lemon juice mixed with 40 ml mineral water thrice daily for two months. They all were advised not to take heavy meal rich with any type of fat like junk food etc. One hour daily brisk walk was advised to all participants. 15 days follow up visit was scheduled for them. After two months their lipid profile was re-determined. When results were compiled and statistically analyzed by applying paired ‘t’ test, it revealed that Curcuma longa decreased total cholesterol, TG, LDL cholesterol 16.10, 20.01, and 17.59 mg/dl respectively. Fenugreek decreased total cholesterol, TGs, and LDL cholesterol 14.70, 17.33, and 17.06 mg/dl respectively. Lemon in two months therapy decreased total cholesterol, TGs, and LDL cholesterol 15.45, 10.13, and 11.97 mg/dl respectively. None of the above mentioned herbs raised HDL cholesterol significantly. It was concluded from this research work that Curcuma longa, Fenugreek leaves and Lemon are mild to moderately effective hypolipidemic herbs to lower total plasma cholesterol, triglycerides, and LDL cholesterol but have no potential to raise HDL cholesterol when analyzed biostatistically.

Keywords: Galactomannan fiber; Hyperlipidemia; Curcuma Longa

Citation: Khoso MI, Abro S, Murad S, Maka TA, Abro W, et al. (2020) Galactomannan Fiber and Alkaloids for Hyperlipidemia. Clin Pharmacol Biopharm 9: 202 Doi: 10.4172/2167-065X.1000202

Copyright: © 2020 Khoso MI, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top